Atopic Dermatitis Clinical Trials

Birmingham :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Mobile :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Hot Springs :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

La Jolla : Research Center

Systemic Sclerosis / Scleroderma Study

Los Angeles : Research Center

Systemic Sclerosis / Scleroderma Study

Redwood City : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Encino :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Oceanside :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

San Diego :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Denver :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Farmington : Research Center

Systemic Sclerosis / Scleroderma Study

Washington : Research Center

Systemic Sclerosis / Scleroderma Study

Tampa : Olympian Clinical Research

Do you have Atopic Dermatitis and have been treated with Protopic (tacrolimus ointment)?

View More »

Jacksonville :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Miami :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Miramar :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Orange Park :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Pinellas Park :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Tampa :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Tampa :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Boise :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Chicago : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Chicago : Northwestern University, Department of Dermatology

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Carmel :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Baltimore : Research Center

Systemic Sclerosis / Scleroderma Study

Boston : Research Center

Systemic Sclerosis / Scleroderma Study

Ann Arbor : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Fort Gratiot :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

New Brunswick : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Verona :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Lake Success : Research Center

Systemic Sclerosis / Scleroderma Study

New York : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

New York : Call for Information (Investigational Site 0002) Updated

A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)

Stony Brook :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

High Point :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Salem :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Winston-Salem : Wake Forest University Health Sciences

Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis

Cleveland : Research Center

Systemic Sclerosis / Scleroderma Study

Toledo : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Sylvania :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Oklahoma City : Research Center

Systemic Sclerosis / Scleroderma Study

Lake Oswego :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Portland :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Portland :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Portland : Oregon Health & Science University Center for Health & Healing

Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants

Portland : Oregon Health & Science University, Department of Dermatology

Eczema Prevention Study

View More »

Portland : Oregon Health & Science University Department of Dermatology

VANOS Cream and Skin Barrier Function

Philadelphia : Paddington Testing Co., Inc

Atopic Dermatitis

Philadelphia : Research Center

Systemic Sclerosis / Scleroderma Study

Pittsburgh : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Philadelphia : Registry

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Johnston :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Charleston : Research Center

Systemic Sclerosis / Scleroderma Study

Houston : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

College Station :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

College Station :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Dallas :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Houston : University of Texas Medical School - Houston

A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

San Antonio :

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

San Antonio :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Webster :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Salt Lake City : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Draper :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Henrico :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Norfolk :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Seattle : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Spokane :

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

Vienna : Novartis Investigative Site

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

London, Ontario : Research Center

Systemic Sclerosis / Scleroderma Study

Montreal, Quebec : Research Center

Systemic Sclerosis / Scleroderma Study

Toronto, Ontario : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Kirkland : Merck Frosst Canada Ltd. Updated

A Study of Intravenous MK-8226 in Participants With Moderate-to-Severe Atopic Dermatitis (MK-8226-003 AM2)

Nachod :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Svitavy :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Usti nad Labem :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Tallinn :

Emollients in the Management of Atopic Dermatitis

Tartu :

Emollients in the Management of Atopic Dermatitis

Helsinki :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Tampere :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Bordeaux : Research Center

Systemic Sclerosis / Scleroderma Study

Caen : Research Center

Systemic Sclerosis / Scleroderma Study

Lille : Research Center

Systemic Sclerosis / Scleroderma Study

Paris : Research Center

Systemic Sclerosis / Scleroderma Study

Strasbourg : Research Center

Systemic Sclerosis / Scleroderma Study

Toulouse : Research Center

Systemic Sclerosis / Scleroderma Study

Bad Nauheim : Research Center

Systemic Sclerosis / Scleroderma Study

Baden-Baden : Research Center

Systemic Sclerosis / Scleroderma Study

Berlin : Research Center

Systemic Sclerosis / Scleroderma Study

Bochum : Research Center

Systemic Sclerosis / Scleroderma Study

Dresden : Research Center

Systemic Sclerosis / Scleroderma Study

Erlangen : Research Center

Systemic Sclerosis / Scleroderma Study

Frankfurt/Main : Research Center

Systemic Sclerosis / Scleroderma Study

Hamburg : Research Center

Systemic Sclerosis / Scleroderma Study

Köln : Research Center

Systemic Sclerosis / Scleroderma Study

Tübingen : Research Center

Systemic Sclerosis / Scleroderma Study

Ulm : Research Center

Systemic Sclerosis / Scleroderma Study

View More »

Berlin :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Berlin :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Bonn :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Dresden :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Erfurt :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Frankfurt :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Frankfurt :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Gera :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Hannover :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Heidelberg :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Kiel :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Mahlow :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Mainz :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Münster :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Osnabrueck :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Tuebingen :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Kaposvar :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szeged :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szekszard :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Szolnok :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Vilnius :

Emollients in the Management of Atopic Dermatitis

Bydgoszcz :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Gdansk :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Lodz :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Lublin :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Poznan :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

View More »

Warszawa :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Warszawa :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Witosa :

Study of REGN668 in Adult Patients With Extrinsic Moderate-to-Severe Atopic Dermatitis

Wroclaw :

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

New Taipei City : Taipei Hospital, Department of Health, Taiwan, R.O.C.

Probiotics and Allergic Diseases

Cannock : Research Center

Systemic Sclerosis / Scleroderma Study

Dundee : Research Center

Systemic Sclerosis / Scleroderma Study

Edinburgh : Research Center

Systemic Sclerosis / Scleroderma Study

Leeds : Research Center

Systemic Sclerosis / Scleroderma Study

Liverpool : Research Center

Systemic Sclerosis / Scleroderma Study

London : Research Center

Systemic Sclerosis / Scleroderma Study

Middlesbrough : Research Center

Systemic Sclerosis / Scleroderma Study

Newcastle upon Tyne : Research Center

Systemic Sclerosis / Scleroderma Study

Romford : Research Center

Systemic Sclerosis / Scleroderma Study